CD8A and neoplasm: Studies from the retrospectively analyzed clinical tumor tissues of breast cancer patients further demonstrated that tumor-infiltrating CD8+ T cells and FoxP3+ T cells are important components for assessing disease prognosis and clinical progression [29-32].